Saliba Walid, Reddy Vivek Y, Wazni Oussama, Cummings Jennifer E, Burkhardt J David, Haissaguerre Michel, Kautzner Josef, Peichl Petr, Neuzil Petr, Schibgilla Volker, Noelker Georg, Brachmann Johannes, Di Biase Luigi, Barrett Conor, Jais Pierre, Natale Andrea
Section of Cardiac Electrophysiology and Pacing, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
J Am Coll Cardiol. 2008 Jun 24;51(25):2407-11. doi: 10.1016/j.jacc.2008.03.027.
We present the initial clinical human experience with the use of a robotic remote navigation system (Hansen Medical, Mountain View, California), to perform left and right atrial mapping and radiofrequency ablation of atrial fibrillation (AF) and atrial flutter (AFL).
Catheter ablation is an established curative modality for various arrhythmias. A robotic steerable sheath system (SSS) (Hansen Medical) allows better catheter stability and greater degrees of freedom of catheter movement.
A total of 40 patients (mean age 57 years) with antiarrhythmic drug (AAD)-refractory AF (23 had also concomitant documented typical AFL) were studied. Three-dimensional reconstruction of the corresponding atrial chamber anatomy was performed with the CARTO electroanatomic mapping system (Biosense Webster, Diamond Bar, California or the EnSite NavX system (St. Jude Medical, Minneapolis, Minnesota) in combination with the Artisan catheter (Hansen Medical). In patients undergoing AF ablation, 2 transseptal punctures were performed under intracardiac ultrasound (ICE) guidance, with one of the punctures being performed using SSS. Pulmonary vein antrum isolation was performed with a 3.5-mm thermocool catheter manipulated with the use of the SSS and was verified by circular mapping. Patients were followed clinically for recurrence of arrhythmia with an event transmitter and ambulatory holter monitoring. Clinical recurrence of AF/AFL was defined as AF/AFL episodes >1 min in duration.
Pulmonary vein antrum isolation was performed in 40 patients, including 23 with concomitant typical AFL ablation. All pulmonary veins, including the superior vena cava, were successfully isolated. In 23 of 40 patients, cavotricuspid ablation was also performed with bidirectional block obtained. At 1-year follow-up, 34 patients (86%) and 5 patients were free from atrial arrhythmia off AADs and on AADs, respectively.
This preliminary human experience suggests that mapping and ablation of AFL and AF using this novel robotic catheter with remote control system is feasible with similar results to conventional approach.
我们展示了使用机器人远程导航系统(汉森医疗公司,加利福尼亚州山景城)进行左、右心房标测以及房颤(AF)和房扑(AFL)射频消融的初步临床人体经验。
导管消融是治疗各种心律失常的既定有效方法。机器人可操纵鞘管系统(SSS)(汉森医疗公司)可实现更好的导管稳定性和更大的导管移动自由度。
共研究了40例(平均年龄57岁)对抗心律失常药物(AAD)难治的房颤患者(其中23例还伴有记录在案的典型房扑)。使用CARTO电解剖标测系统(百盛韦伯斯特公司,加利福尼亚州钻石吧或EnSite NavX系统(圣犹达医疗公司,明尼苏达州明尼阿波利斯)结合工匠导管(汉森医疗公司)对相应心房腔解剖结构进行三维重建。在接受房颤消融的患者中,在心脏内超声(ICE)引导下进行2次经房间隔穿刺,其中1次穿刺使用SSS。使用SSS操纵3.5毫米冷盐水灌注导管进行肺静脉前庭隔离,并通过环形标测进行验证。通过事件发射器和动态心电图监测对患者进行临床随访,观察心律失常复发情况。房颤/房扑的临床复发定义为持续时间>1分钟的房颤/房扑发作。
40例患者进行了肺静脉前庭隔离,其中23例还进行了典型房扑消融。所有肺静脉,包括上腔静脉,均成功隔离。40例患者中有23例还进行了三尖瓣峡部消融,并实现了双向阻滞。在1年随访时,分别有34例(86%)和5例患者在停用AAD和使用AAD时无房性心律失常。
这一初步人体经验表明,使用这种新型遥控机器人导管进行房扑和房颤的标测及消融是可行的,结果与传统方法相似。